Skip to content
DataLookout
Menu

NCT07211932

Tofacitinib in Juvenile Idiopathic Arthritis

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 2 with changes below, 1 re-verified with no change.

  1. Notable Primary and study completion pushed from Dec 2026 to Dec 2027
    • Recruitment opened
    • Trial sites expanded: 3 → 7 locations
    • Start date changed from estimate of Dec 2025 to Feb 2, 2026
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

JADAS-10
Timeframe: Baseline and 12 months

Arms and interventions

Tofacitinib

Patients affected by JIA and treated with tofacitinib

Drugs: Tofacitinib

Sites

7 sites in 1 country